about
Optic nerve head and fibre layer imaging for diagnosing glaucomaTopical medication instillation techniques for glaucomaOptic nerve head and fibre layer imaging for diagnosing glaucomaCyclodestructive procedures for refractory glaucomaDiabetes Mellitus as a Risk Factor in Glaucoma's Physiopathology and Surgical Survival Time: A Literature ReviewPalmitoylethanolamide, a Natural Retinoprotectant: Its Putative Relevance for the Treatment of Glaucoma and Diabetic RetinopathyThe significance of intraocular pressure elevation during sleep-related posturesA lymphatic defect causes ocular hypertension and glaucoma in miceTonographic Effect of Ocular Response Analyzer in Comparison to Goldmann Applanation TonometryBimatoprost-loaded ocular inserts as sustained release drug delivery systems for glaucoma treatment: in vitro and in vivo evaluationScan quality effect on glaucoma discrimination by glaucoma imaging devicesPharmacotherapy of intraocular pressure: part I. Parasympathomimetic, sympathomimetic and sympatholytics.Ocular changes in primary hypothyroidismIntraocular pressure reduction with a fixed treatment protocol in the Early Manifest Glaucoma Trial.Predicting Future Self-Reported Motor Vehicle Collisions in Subjects with Primary Open-Angle Glaucoma Using the Penalized Support Vector Machine MethodThe microbead occlusion model: a paradigm for induced ocular hypertension in rats and mice.Risk factors for glaucoma suspicion in healthy young asian and caucasian americans.Astrocyte Reactivity: A Biomarker for Retinal Ganglion Cell Health in Retinal NeurodegenerationSignificant correlations between optic nerve head microcirculation and visual field defects and nerve fiber layer loss in glaucoma patients with myopic glaucomatous disk.The Benefits of Calorie Restriction and Calorie Restriction Mimetics as Related to the Eye.Common genetic determinants of intraocular pressure and primary open-angle glaucoma.Frequency doubling technology, optical coherence technology and pattern electroretinogram in ocular hypertensionTopical medication instillation techniques for glaucoma.Lipofuscin in human glaucomatous optic nerves.Comparison of retinal nerve fiber layer thickness in vivo and axonal transport after chronic intraocular pressure elevation in young versus older rats.Oxygen distribution in the human eye: relevance to the etiology of open-angle glaucoma after vitrectomyA 6-month study comparing efficacy, safety, and tolerability of the preservative-free fixed combination of tafluprost 0.0015% and timolol 0.5% versus each of its individual preservative-free components.The relationship between central visual field damage and motor vehicle collisions in primary open-angle glaucoma patientsAdeno-associated virus-mediated expression of growth-associated protein-43 aggravates retinal ganglion cell death in experimental chronic glaucomatous injury.Laser scanning tomography in the EPIC-Norfolk Eye Study: principal components and associations.Comprehensive Review of the Effects of Diabetes on Ocular Health.Intraocular pressure-lowering efficacy and safety of bimatoprost 0.03% therapy for primary open-angle glaucoma and ocular hypertension patients in China.Pharmacotherapy of glaucoma.Glaucomatous visual field defect severity and the prevalence of motor vehicle collisions in Japanese: a hospital/clinic-based cross-sectional studyAn assessment of the health and economic burdens of glaucomaEstimation of 24-Hour Intraocular Pressure Peak Timing and Variation Using a Contact Lens Sensor.Trends in Glaucoma Medication Expenditures under Universal Health Coverage: A National Population-Based Longitudinal Survey in Taiwan.Prevalence and risk factors of primary open-angle glaucoma in a city of Eastern China: a population-based study in Pudong New District, Shanghai.Assessment of Filtration Bleb and Endplate Positioning Using Magnetic Resonance Imaging in Eyes Implanted with Long-Tube Glaucoma Drainage Devices.Improving Access to Eye Care among Persons at High-Risk of Glaucoma in Philadelphia--Design and Methodology: The Philadelphia Glaucoma Detection and Treatment Project
P2860
Q24187597-4B2CC3FD-6DE0-4521-81FC-061B757CEF2CQ24197532-C24439D6-0E8D-4550-BF0B-B889E1074437Q24236729-4B195352-E173-4C72-A192-0E718756398CQ26471740-CA88302B-2D77-475C-AC2F-1F1366A26047Q26753166-4CADB167-1052-4EB2-ABD5-3CABA5C468D8Q26776171-9468BE87-3020-48C7-90C0-C5F20B1E18AAQ26825794-FEE02BDC-F120-4BE1-AD8E-DCB599305B8DQ28247543-F5AA7495-AFFD-44A4-ADEA-5B4AC07FA6A3Q28469497-A0AC9B15-618C-49A0-9F32-464AC8339F9EQ28538289-D7121259-30BE-452C-9589-4E1BEA88083FQ33495034-4AC3EEF3-BBA4-4AA1-95D6-AD57802A7B3DQ33513713-5308A9FA-9AB1-4A60-B3CB-E16EEE1D01F9Q33521122-995ACE28-A8EB-48A3-AC13-9559C8ABDE1BQ33541683-03E7C5DA-D59A-4144-8547-80F1FEC1D19BQ33778876-E56A90A3-0E5A-427B-89D6-C5F6F98875CAQ33847407-A91F674B-FBF3-4664-8F18-E2822AA433AFQ34033476-174FC635-A726-453E-A40A-DE5D5B4B9983Q34040388-67A682FB-CFE9-48A2-B719-53DD2DF7EF9DQ34113430-11B6270E-6247-40D4-8E3C-AF53F73C5E89Q34125724-50FAE2C0-D051-4638-AF80-00D7A32BD1DAQ34263126-BA045704-7998-4521-9D9C-BE1613352EBAQ34361690-C3A77BFF-280F-4DDE-A1AB-02C7F9C4186AQ34551634-293DE92B-8F46-488E-856B-3D84D0FC507DQ34659679-443CC8E2-128C-4FAB-97BF-004B5B9CD22EQ34682128-A028FF5D-DA2B-414D-B125-F1F2A5DCBEF9Q34702107-249DCE30-EA48-4C89-A1F2-05B57E5658E7Q34737181-399D57FD-0886-4C61-A441-A1848590F16AQ34783264-63E93A65-28F4-4235-980E-186A8751061BQ34795350-1DF6596E-895D-4D27-AB46-C2D5183179ADQ34986167-C0D47287-DDC6-473A-A095-48E13989B26AQ35099333-CD90A36E-6D6C-4653-891F-807126CFF00BQ35102806-82FFAD3F-00A2-41CA-9362-9EBE4C92A8BCQ35138049-0AA6DBDB-D939-4C9F-8A05-F2C391068579Q35422056-2AD9D7A0-2421-4F80-8C57-7210746BDAE1Q35506935-28E1365C-7F6E-4F5D-B5B1-A56A5C0BF4F2Q35664270-A0A940E7-63C3-43A8-BF03-1955DC44B0B8Q35744956-E3A92FCA-C16C-46F5-8769-C251A3B233D6Q35805112-FAD76655-AED4-48AA-B9F6-4C34EEAFC36EQ35862162-33FA875A-7682-4B88-96C6-3B01C9368366Q35947606-3593149E-F54E-4F93-A31C-B9E6C7D75CE0
P2860
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Risk factors for glaucoma onset and progression.
@en
Risk factors for glaucoma onset and progression.
@nl
type
label
Risk factors for glaucoma onset and progression.
@en
Risk factors for glaucoma onset and progression.
@nl
prefLabel
Risk factors for glaucoma onset and progression.
@en
Risk factors for glaucoma onset and progression.
@nl
P1476
Risk factors for glaucoma onset and progression.
@en
P2093
Anne L Coleman
Stefano Miglior
P356
10.1016/J.SURVOPHTHAL.2008.08.006
P478
P577
2008-11-01T00:00:00Z